On Friday, Shares of LPL Financial Holdings Inc. (NASDAQ:LPLA), dropped -0.30% to $40.35.
LPL Financial Holdings, declared assets of $485 billion as of March 31, 2015, up 9% contrast to the end of the first quarter of 2014. Year-over-year revenue grew 2% to $1.1 billion and earnings per share grew 2%, or $0.01.
Few Key Business Highlights
Record Net New Advisory Asset Flows. Net new advisory assets, which exclude the impact of market movement, were $5.2 billion for the three months ended March 31, 2015, primarily driven by strong advisor productivity and the continued addition of hybrid registered investment advisors.
Hybrid RIA Assets Surpass $100 Billion Milestone. Assets under custody on LPL Financial’s Hybrid RIA platform, which provides an integrated offering of technology, clearing, compliance, and custody services to Hybrid RIAs, grew 50.6% to $104.8 billion as of March 31, 2015, representing 342 Hybrid RIA firms, contrast to $69.6 billion and 265 Hybrid RIA firms as of March 31, 2014.
Strong Fundamentals Drive Record Gross Profit. Key contributors to first quarter gross profit growth comprised of:
- $38.3 billion enhance in total advisory and brokerage assets since March 31, 2014
- 372 net new advisors added since March 31, 2014
LPL Financial Holdings Inc., together with its auxiliaries, provides an integrated platform of brokerage and investment advisory services to independent financial advisors and financial advisors at financial institutions in the United States.
Shares of Varian Medical Systems, Inc. (NYSE:VAR), declined -0.29% to $88.59, during its last trading session.
Varian Medical Systems, and Sarah Cannon, declared a new initiative to upgrade the radiation oncology equipment across the Sarah Cannon Cancer Network of Excellence with newly advanced technology for image-guided, high-precision radiotherapy and radiosurgery. Sarah Cannon will also deploy Varian’s new InSightive™ software for data analytics and RapidPlan™ knowledge-based treatment planning software together with Varian’s ARIA® information administration and Eclipse™ treatment planning software. The software will support Sarah Cannon’s programs for using data to develop personalized treatment plans, improve outcomes, and expand clinical trial options for patients.
The project is part of a long-term plan for enhancing and expanding radiotherapy and radiosurgery cancer treatment capabilities across the Sarah Cannon Cancer Network of Excellence. Sarah Cannon has access to more than 100,000 newly-diagnosed cancer patients per year and offers integrated cancer services with convenient access to cutting-edge therapies through its network of cancer programs across the United States and United Kingdom.
Over the next 18 months Sarah Cannon will install six Varian TrueBeam™ systems for image-guided radiotherapy and radiosurgery, in addition to a Clinac® machine for image-guided intensity-modulated radiation therapy (IMRT), a highly precise method of focusing radiation on a tumor while minimizing exposure of surrounding healthy tissues and organs. The new TrueBeam systems will enable Sarah Cannon raised levels of versatility, efficiency, reliability, and a lower cost per patient in offering advanced treatments like stereotactic radiosurgery.
Varian booked the Sarah Cannon order during its fiscal second quarter and will book revenues in accordance with the company’s policies over the term of the agreement.
Varian Medical Systems, Inc. designs, manufactures, sells, and services medical devices and software products for treating cancer and other medical conditions in the United States. The company operates in two segments, Oncology Systems and Imaging Components.
Finally, Moody’s Corporation (NYSE:MCO), ended its last trade with -0.28% loss, and closed at $107.22, hitting its highest level.
Moody’s Corporation, declared results for the first-quarter 2015.
FIRST-QUARTER 2015 HIGHLIGHTS
Moody’s Corporation stated revenue of $865.6 million for the three months ended March 31, 2015, up 13% from $767.2 million for same period of 2014.
Operating expense in first-quarter 2015 totaled $494.3 million, a 14% enhance from $434.2 million. Operating income was $371.3 million, up 12% from $333.0 million. Adjusted operating income (operating income before depreciation and amortization) was $399.9 million, up 12% from $356.1 million. Operating margin for first-quarter 2015 was 42.9%, and adjusted operating margin was 46.2%. GAAP EPS of $1.11 was up 11% from first-quarter 2014 GAAP EPS of $1.00.
Moody’s Corporation stated global revenue of $865.6 million for first-quarter 2015, up 13% from first-quarter 2014. Foreign currency translation unfavorably influenced revenue by 5%. U.S. revenue was $499.8 million, up 17% from $425.6 million, while non-U.S. revenue was $365.8 million, up 7% from $341.6 million. Revenue generated outside the U.S. constituted 42% of total revenue, as compared to 45% in the year-ago period.
Moody’s Corporation provides credit ratings; and credit, capital markets, and economic related research, data, and analytical tools worldwide. The company operates through Moodys Investors Service and Moody’s Analytics segments.
DISCLAIMER:
This article is published by www.wsnewspublishers.com. The Content included in this article is just for informational purposes only. All information used in this article is believed to be from reliable sources, but we make no representations or warranties of any kind, express or implied, about the completeness, accuracy, or reliability with respect to this article.
All visitors are advised to conduct their own independent research into individual stocks before making a purchase decision.
Information contained in this article contains forward-looking information within the meaning of Section 27A of the Securities Act of 1933 and Section 21E of the Securities Exchange Act of 1934, counting statements regarding the predictable continual growth of the market for the corporation’s products, the corporation’s ability to fund its capital requirement in the near term and in the long term; pricing pressures; etc.
Any statements that express or involve discussions with respect to predictions, expectations, beliefs, plans, projections, objectives, aims, assumptions, or future events or performance may be forward looking statements. Forward-looking statements are based on expectations, estimates, and projections at the time the statements are made that involve a number of risks and uncertainties which could cause actual results or events to differ materially from those presently anticipated. Forward looking statements may be identified through the use of such words as expects, will, anticipates, estimates, believes, or by statements indicating certain actions may, could, should might occur.
